Exosomes derived from myelodysplastic syndromes cells induce IL-1β production from macrophages to promote disease

Peichun Li1, Dongmei Guan1, Shuo Li1

  • 1Shanxi Medical University, 56 Xinjian South Road, Taiyuan, Shanxi Province, China.

Cytokine
|March 27, 2025
PubMed
Abstract

Insights

Exosomes from MDS cells promote macrophage release of IL-1β, driving MDS progression. This study reveals a novel mechanism involving exosomes and macrophages in myelodysplastic syndromes.

Area of Science:

  • Cell Biology
  • Immunology
  • Oncology

Background:

  • Exosomes mediate intercellular communication, material transport, and immunity.
  • Myelodysplastic syndromes (MDS) involve dysregulated cell function, influenced by the tumor microenvironment.
  • The role of tumor-derived exosomes in modulating macrophages and impacting MDS progression is largely unknown.

Purpose of the Study:

  • To investigate the effect of exosomes on macrophage function.
  • To explore how macrophage-secreted cytokines influence MDS cells.
  • To elucidate the mechanisms of exosome and macrophage involvement in MDS progression.

Main Methods:

  • Analyzed peripheral blood cytokine levels in MDS patients.
  • Co-cultured MDS cell line exosomes with induced THP-1-derived macrophages (Mφ).
  • Utilized flow cytometry, Q-PCR, and Western blotting to assess cytokine release, Mφ differentiation, and signaling pathways (MER/ERK).

Main Results:

  • Elevated IL-1β levels were observed in MDS patients' peripheral blood.
  • MDS-derived exosomes promoted IL-1β release from Mφ and enhanced MDS cell proliferation, apoptosis, and migration.
  • Exosomes stimulate Mφ to produce IL-1β via the MER/ERK pathway, promoting MDS progression.

Conclusions:

  • MDS cell-derived exosomes modulate macrophages to produce IL-1β.
  • This exosome-macrophage interaction, mediated by the MER/ERK pathway, contributes to MDS progression.
  • Targeting this pathway may offer therapeutic strategies for MDS.